Ticker
TILCompany Name
INSTIL BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 182.07M | $ 7.45M | $ 1.22M | $ 0 | -4.76% |
3/31/2025 | $ 83.57M | $ 769K | $ 1.22M | $ 0 | -2.38% |
12/31/2024 | $ 114.2M | $ 365K | $ 1.39M | $ 0 | -1.54% |
9/30/2024 | $ 205.83M | $ 159K | $ 0 | $ 0 | -0.08% |
6/30/2024 | $ 67.32M | $ 0 | $ -587K | $ 0 | 0.87% |
3/31/2024 | $ 75.32M | $ 0 | $ 3.62M | $ 0 | -4.8% |
12/31/2023 | $ 76.55M | $ 0 | $ 8.08M | $ 0 | -10.56% |
9/30/2023 | $ 46.83M | $ 376K | $ 13.91M | $ 0 | -30.5% |
6/30/2023 | $ 64.26M | $ 645K | $ 28.95M | $ 0 | -46.05% |
3/31/2023 | $ 80.23M | $ 1.21M | $ 74.81M | $ 0 | -94.74% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for INSTIL BIO INC is calculated as follows: (-1 * CF - Equity [ $ 365K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.12% |